Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an announcement.
ResMed Inc.’s Chief Financial Officer, Brett Sandercock, executed a transaction under a Rule 10b5-1 plan, selling 1,000 shares of common stock at $238.98 per share. This planned transaction, which reflects strategic financial management, may impact stakeholders’ perceptions of the company’s financial strategy and market approach.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, focusing on developing and manufacturing equipment for treating sleep disorders, including sleep apnea. The company is known for its innovative products like CPAP devices and masks that are used worldwide to improve sleep health.
YTD Price Performance: 3.10%
Average Trading Volume: 972,805
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.47B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.
